Role of tyrosine phosphorylation in the antioxidant effects of the p75 neurotrophin receptor

Oxidative Medicine and Cellular Longevity

Volumn 2, Issue 4, 2009, Pages 238-246

  Zhang, Tong ^a   Mi, Zhiping ^a   Schor, Nina F ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Neurotrophin receptors; Neurotrophins; Oxidative stress; Reactive oxygen species; Tyrosine phosphorylation

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROTROPHIN RECEPTOR P75;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; NONHUMAN; OXIDATIVE STRESS; PHEOCHROMOCYTOMA CELL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SITE DIRECTED MUTAGENESIS;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTAGENESIS, SITE-DIRECTED; NEURONS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RECEPTOR, NERVE GROWTH FACTOR; TYROSINE;

RATTUS;

EID: 77953399351     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.2.4.9745     Document Type: Article

References (20)

1. Tyurina YY, Nylander KD, Mirnics ZK, Portugal C, Yan C, Zaccaro C, et al. The intracellular domain of p75NTR as a determinant of cellular reducing potential and response to oxidant stress. Aging Cell 2005; 4:187-96.
2. Zampieri N, Xu CF, Neubert TA, Chao MV. Cleavage of p75 neurotrophin receptor by alpha-secretase and gamma-secretase requires specific receptor domains. J Biol Chem 2005; 280:14563-71.
3. Blöchl A, Blumenstein L, Ahmadian MR. Inactivation and activation of ras by the neurotrophin receptor p75. Eur J Neurosci 2004; 20:2321-35.
4. Ohrt T, Mancini A, Tamura T, Niedenthal R. c-cbl binds to tyrosine-phosphorylated neurotrophin receptor p75 and induces its ubiquitination. Cell Signal 2004; 16:1291-8.
5. Mirnics K, Korade Z, Arion D, Lazarov O, Unger T, Macioce M, et al. Presenilin-1-dependent transcriptome changes. J Neurosci 2005; 25:1571-8.
6. Korade Z, Mi Z, Portugal C, Schor NF. Expression and p75 neurotrophin receptor dependence of cholesterol synthetic enzymes in adult mouse brain. Neurobiol Aging 2007; 28:1522-31.
7. Yan C, Mirnics ZK, Portugal CF, Liang Y, Nylander KD, Rudzinski M, et al. Cholesterol biosynthesis and the pro-apoptotic effects of the p75 nerve growth factor receptor in PC12 pheochromocytoma cells. Brain Res Mol Brain Res 2005; 139:225-34.
8. Wang JJ, Tasinato A, Ethell DW, Testa MP, Bredesen DE. Phosphorylation of the common neurotrophin receptor p75 by p38β2 kinase affects NF-kB and AP-1 activities. J Mol Neurosci. 2000; 15:19-29.
9. Miloso M, Scuteri A, Foudah D, Tredici G. MAPKs as mediators of cell fate determination: An approach to neurodegenerative diseases. Curr Med Chem 2008; 15:538-48.
10. Wang X, Li H, Chen Y, Fu J, Ren Y, Dong L, et al. p28GANK knockdown-derived reactive oxygen species induces apoptosis through mitochondrial dysfunction mediated by p38 in HepG2 cells. Int J Oncol 2008; 33:743-50.
11. Kulich SM, Chu CT. Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: Implications for parkinson's disease. J Neurochem 2001; 77:1058- 66.
12. Luo Y, DeFranco DB. Opposing roles for ERK1/2 in neuronal oxidative toxicity: Distinct mechanisms of ERK1/2 action at early versus late phases of oxidative stress. J Biol Chem 2006; 281:16436-42.
13. Allen J, Khwaja F, Byers S, Djakiew D. The p75NTR mediates a bifurcated signal transduction cascade through the NFkB and JNK pathways to inhibit cell survival. Exp Cell Res 2005; 304:69-80.
14. Costantini C, Rossi F, Formaggio E, Bernardoni R, Cecconi D, Della-Bianca V. Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in b-amyloid peptide-dependent cell death. J Mol Neurosci 2005; 25:141-56.
15. Puttonen KA, Lehtonen S, Lampela P, Mannisto PT, Raasmaja A. Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines. Toxicology in vitro 2008; 22:182-9.
16. Putt KS, Beilman GJ, Hergenrother PJ. Direct quantitation of poly(ADPribose) polymerase (PARP) activity as a means to distinguish necrotic and apoptotic death in cell and tissue samples. Chembiochem 2005; 6:53-5.
17. Eshleman AJ, Neve RL, Janowsky A, Neve KA. Characterization of a recombinant human dopamine transporter in multiple cell lines. J Pharmacol Exp Ther 1995; 274:276-83.
18. Rubenstein R, Price RW. Preservation of catecholamine uptake and release in herpes simplex virus type 1-infected PC12 cells. J Gen Virol 1983; 64:2505-9.
19. Barker PA, Shooter EM. Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC12 cells. Neuron 1994; 13:203-15.
20. Chandler CE, Parsons LM, Hosang M, Shooter EM. A monoclonal antibody modulates the interaction of nerve growth factor with PC12 cells. J Biol Chem 1984; 259:6882-9.